Doctor profile · Federal record

Dr. Daniel Zanchetti, M.D.

Gastroenterology Physician (CMS: Gastroenterology) · New Haven, CT

  • NPI 1821257742
  • Accepts Medicare
  • MIPS 71.7 / 100 · 2023
  • 18 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
40 Temple St, Suite 4A
New Haven, CT 065102715
(203) 777-0304
fax (203) 562-9316

Credentials & registration

NPPES · NUCC
NPI registered
June 2008 — 18 yrs on file
Profile last updated
July 30, 2015
Year of graduation
2008 — 18 yrs since
Specialty taxonomy
207RG0100X — NUCC code
State license (1)
Connecticut #053983

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1821257742. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
12,430
Distinct HCPCS
10
Medicare allowed
$368,855
HCPCS Description Services Patients Avg allowed
J3380 Injection, vedolizumab, 1 mg 9,600 14 $22
J1745 Injection, infliximab, excludes biosimilar, 10 mg 2,140 16 $33
99214 Established patient office or other outpatient visit, 30-39 minutes 232 122 $137
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare 70 69 $266
45380 Biopsy of large bowel using a flexible endoscope 60 60 $68
99213 Established patient office or other outpatient visit, 20-29 minutes 56 47 $96
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope 53 52 $100
96413 Administration of chemotherapy into vein, 1 hour or less 44 18 $145
96415 Administration of chemotherapy into vein, each additional hour 39 16 $31
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 33 15 $71

In context: peer comparison

Among 19 peers in this city , average services per provider: 110. This provider delivers 113× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,008
Transactions
48
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 14 $229.27
Phathom Pharmaceuticals, Inc. 7 $162.35
QOL Medical, LLC 3 $101.32
Ardelyx, Inc. 4 $97.28
Janssen Biotech, Inc. 4 $90.71
Takeda Pharmaceuticals U.S.A., Inc. 2 $55.49
AIMMUNE THERAPEUTICS, INC. 2 $49.86
Salix Pharmaceuticals, a division of Bausch Health US, LLC 2 $47.05
Celltrion USA Inc. 3 $43.51
PFIZER INC. 2 $34.27
Lilly USA, LLC 1 $23.33
GENZYME CORPORATION 1 $23.14
Gilead Sciences, Inc. 1 $21.86
Regeneron Healthcare Solutions, Inc. 1 $15.16
IRONWOOD PHARMACEUTICALS, INC 1 $13.85

By nature of payment

Food and Beverage
$979
Education
$29

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,348
Patients
466
Total drug cost
$337,868
Drug Type Claims Patients Total cost
Pantoprazole Sodium Generic 321 97 $5,748
Famotidine Generic 243 70 $5,034
Omeprazole Generic 233 69 $4,672
Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates) Brand 94 90 $7,292
Dicyclomine Hcl Generic 83 31 $999
Mesalamine Generic 54 16 $49,230
Linzess (Linaclotide) Brand 50 14 $48,784
Sutab (Sod Sulf/Pot Chloride/Mag Sulf) Brand 45 44 $7,714
Creon (Lipase/Protease/Amylase) Brand 39 0 $166,680
Dexlansoprazole Dr (Dexlansoprazole) Brand 39 12 $13,650

Frequently asked questions

Auto-generated from federal data
What is Dr. Daniel Zanchetti's medical specialty?
Dr. Daniel Zanchetti practices Gastroenterology Physician in New Haven, CT.
Where does Dr. Daniel Zanchetti practice?
Dr. Daniel Zanchetti practices at 40 Temple St, New Haven, CT 065102715. Office phone: 2037770304.
What is Dr. Daniel Zanchetti's NPI?
Dr. Daniel Zanchetti's National Provider Identifier (NPI) is 1821257742, issued by NPPES.
Does Dr. Daniel Zanchetti accept Medicare assignment?
Yes. Dr. Daniel Zanchetti accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Daniel Zanchetti commonly perform?
Top Medicare-reported procedures in 2023: Injection, vedolizumab, 1 mg (HCPCS J3380); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.